You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 4, APRIL 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (38)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Erythermalgia

A Clue to the Early Diagnosis of Myeloproliferative Disorders

DONATO ALARCON-SEGOVIA, MD; RICHARD R. BABB, MD; JOHN F. FAIRBAIRN II, MD; ALBERT B. HAGEDORN, MD

Arch Intern Med. 1966;117(4):511-515.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

ERYTHERMALGIA is a disorder characterized by burning distress of the extremities accompanied by redness and increased temperature of the skin. These symptoms are often initiated by an increase in environmental temperature and relieved by measures that cool the skin.1 Smith and Allen 2 divided erythermalgia into primary and secondary forms depending on whether or not there were associated disease states in the neurologic, vascular, or hematologic systems. In a recent study of 51 cases of erythermalgia seen at the Mayo Clinic in the years 1951 through 1960 we found 21 cases of the secondary form.3 Of particular interest was our finding that in eight patients with a myeloproliferative disease the "secondary" erythermalgia preceded recognition of the hematologic disorder by up to 16 years. We report these cases herein to call attention to this early diagnostic clue.

Material

The myeloproliferative syndrome may be defined as an unexplained, persistent proliferation . . . [Full Text PDF of this Article]


Author Affiliations

ROCHESTER, MINN

From the Mayo Clinic and Mayo Foundation: Section of Medicine (Drs. Fairbairn and Hagedorn). Mayo Graduate School of Medicine, University of Minnesota (Drs. Alarcón-Segovia and Babb).


Footnotes

Received for publication Oct 27, 1965; accepted Jan 28, 1966.

Reprint requests to Section of Publications, Mayo Clinic, Rochester, Minn 55902.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.